QGEN logo

QGEN
Qiagen NV

1,425
Mkt Cap
$7.06B
Volume
1.65M
52W High
$57.82
52W Low
$32.53
PE Ratio
18.13
QGEN Fundamentals
Price
$35.09
Prev Close
$34.24
Open
$34.31
50D MA
$38.14
Beta
0.58
Avg. Volume
1.99M
EPS (Annual)
$2.04
P/B
2.17
Rev/Employee
$369,649.63
$10,556.49
Loading...
Loading...
News
all
press releases
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the global launch of QIA Agent, an AI-powered digital assistant designed to simplify how researchers plan experiments, identify suitable products, access technical information and manage ordering support through a single...
Business Wire·9h ago
News Placeholder
More News
News Placeholder
Qiagen (QGEN) Securities Fraud Investigation - Levi & Korsinsky
Qiagen (QGEN) Securities Fraud Investigation - Levi & Korsinsky Qiagen (QGEN) Securities Fraud Investigation - Levi & Korsinsky PR Newswire NEW YORK, May 20, 2026 Qiagen shares dropped more than 10% after the company slashed FY 2026 sales-growth guidance from "at least 5% CER" to just 1-2% CER...
PR Newswire·16h ago
News Placeholder
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum
ABT's EPD unit posts 9% Q1 sales growth as biosimilars and emerging market demand support its long-term expansion plans.
Zacks·17h ago
News Placeholder
3 Stocks in Focus That Recently Declared Dividend Hikes Amid High Inflation
TSM, QGEN and AG recently raised dividends as inflation, rising Treasury yields and oil prices fuel market volatility and economic concerns.
Zacks·17h ago
News Placeholder
QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V.
The law firm of Kirby McInerney LLP continues its investigation on behalf of Qiagen N.V. (Qiagen or the Company) (NYSE:QGEN) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws and other unlawful business practices. [LEARN...
Business Wire·1d ago
News Placeholder
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced at the 2026 BIO-IT World Conference & Expo in Boston that the QIAGEN Digital Insights bioinformatics business and its curated knowledge...
Business Wire·1d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN...
PR Newswire·6d ago
News Placeholder
QIAGEN N.V. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
The law firm of Kirby McInerney LLP is investigating potential claims against Qiagen N.V. (Qiagen or the Company) (NYSE:QGEN). The investigation concerns whether the Company and/or members of its...
Business Wire·8d ago
News Placeholder
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced proposals for its 2026 Annual General Meeting, including plans to appoint co-founder and former Chief Executive Officer Dr. Metin...
Business Wire·9d ago
News Placeholder
Deciphering Qiagen (QGEN) International Revenue Trends
Examine Qiagen's (QGEN) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Zacks·10d ago
<
1
2
...
>

Latest QGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.